首页 正文

HER2 overexpression/amplification in colorectal cancer: spatial intratumoral heterogeneity as a key determinant of detection discordance and therapy response

{{output}}
HER2-targeted therapy is increasingly used in colorectal cancer (CRC). However, discrepancies between conventional detection methods (immunohistochemistry [IHC]/fluorescence in situ hybridization [FISH]) and next-generation sequencing (NGS) remain to be elucid... ...